SBI Healthcare Opportunities Fund vs Nippon India Taiwan Equity Fund
SBI Healthcare Opportunities Fund (Direct) and Nippon India Taiwan Equity Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Sectoral/ Thematic schemes — see the best sectoral & thematic mutual funds for the full ranking.
Head to head
NAVs as of 29 Oct 2026
Growth of ₹100 (rebased over the selected window)
Common period 14 Dec 2021 – 29 Oct 2026, limited by Nippon India Taiwan Equity Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI Healthcare Opportunities Fund | Nippon India Taiwan Equity Fund | Nifty Healthcare TRI |
|---|---|---|---|
| 14 Dec 2021 | ₹100.00 | ₹100.00 | ₹100.00 |
| 11 May 2022 | ₹90.67 | ₹81.84 | ₹90.14 |
| 07 Oct 2022 | ₹99.52 | ₹67.78 | ₹96.68 |
| 04 Mar 2023 | ₹97.11 | ₹78.11 | ₹87.84 |
| 30 Jul 2023 | ₹125.28 | ₹97.95 | ₹112.57 |
| 26 Dec 2023 | ₹138.81 | ₹99.96 | ₹123.22 |
| 22 May 2024 | ₹159.25 | ₹113.11 | ₹143.89 |
| 17 Oct 2024 | ₹193.44 | ₹124.78 | ₹172.82 |
| 15 Mar 2025 | ₹182.73 | ₹114.23 | ₹154.74 |
| 10 Aug 2025 | ₹195.82 | ₹155.11 | ₹167.66 |
| 05 Jan 2026 | ₹198.06 | ₹193.72 | ₹174.52 |
| 03 Jun 2026 | ₹215.34 | ₹416.76 | ₹181.98 |
| 29 Oct 2026 | ₹237.49 | ₹344.60 | ₹193.38 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
- 35 stocks only in SBI Healthcare Opportunities Fund
- 0 stocks in both — 0.0% of each portfolio by weight
- 31 stocks only in Nippon India Taiwan Equity Fund
The more the circles overlap, the more the funds hold the same stocks.
SBI Healthcare Opportunities Fund and Nippon India Taiwan Equity Fund share 0% of their equity book by weight.
| Metric | SBI · Direct NAV ₹584.91 Very High risk ★★★★★ | Nippon India · Direct NAV ₹33.63 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 257 funds |
|---|---|---|---|
| +16.23% | +85.04%Best in row | -3.21% | |
| +24.48% | +57.92%Best in row | +13.32% | |
| +19.09% | — | +11.41% | |
| +14.66% | — | +14.18% | |
| +17.88% | +28.90% | +11.86% | |
| +21.54% | — | — | |
| +16.38% | +37.07%Best in row | +17.23% | |
| +14.72% | — | +16.02% | |
| +14.78% | — | +15.97% | |
| Risk | |||
| 13.15%Best in row | 36.59% | 15.61% | |
| 1.37 | 1.41 | 0.44 | |
| 1.95 | 2.07Best in row | 0.59 | |
| -30.53% | -44.77% | -22.99% | |
| Nifty Healthcare TRI | — | — | |
| +4.87% | — | +2.53% | |
| 0.85 | — | 0.95 | |
| 96.0% | — | 98.1% | |
| 73.6% | — | 91.8% | |
| 1.01%Best in row | 1.08% | 1.15% | |
| ₹5,565Cr | ₹1,100Cr | ₹1,202Cr | |
| — | 1.00% | — | |
| — | ₹100 | — | |
| — | ₹2.02K | — | |
| 34% | 61% | 52% | |
| Tanmaya Desai | Kinjal Desai | — | |
| NAV since 02 Jan 2013 | 11 Dec 2021 | — | |
| 35 | 31 | — | |
| 51.8% | 47.8% | — | |
| 4.4% | 9.2% | — | |
1 row carries the same value for every fund — show
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — SBI Healthcare Opportunities Fund or Nippon India Taiwan Equity Fund?
Over the last 3 years, Nippon India Taiwan Equity Fund returned +57.92% CAGR against SBI Healthcare Opportunities Fund's +24.48%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — SBI Healthcare Opportunities Fund or Nippon India Taiwan Equity Fund?
SBI Healthcare Opportunities Fund has the lower expense ratio: SBI Healthcare Opportunities Fund charges 1.01% a year against Nippon India Taiwan Equity Fund's 1.08%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — SBI Healthcare Opportunities Fund or Nippon India Taiwan Equity Fund?
Nippon India Taiwan Equity Fund has shown higher volatility (+36.59% annualized vs SBI Healthcare Opportunities Fund's +13.15%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: SBI Healthcare Opportunities Fund -13.51% vs Nippon India Taiwan Equity Fund -37.58%.
Which fund manages more money — SBI Healthcare Opportunities Fund or Nippon India Taiwan Equity Fund?
SBI Healthcare Opportunities Fund is the larger fund: SBI Healthcare Opportunities Fund manages ₹5,565Cr against Nippon India Taiwan Equity Fund's ₹1,100Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are SBI Healthcare Opportunities Fund and Nippon India Taiwan Equity Fund in the same category?
Yes — both are Sectoral/ Thematic schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.